EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Signet-Ring Cell Colorectal Cancer and Signet-Ring Cell Component Colorectal Cancer: Do They Differ in Clinical Behavior?

Cebrail Akyuz iD, Oguzhan Sunamak iD, Aytac Selman iD, Mehmet O Gul iD, Umut Kina Kilicaslan, Kadir Corbaci iD, Feza Ekiz iD, Turgut Donmez iD, Evren Besler iD

Journal of Clinical Medicine · 04.04.2026 · 15 (7) · 2736

DOI: 10.3390/jcm15072736 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 04.04.2026. Verfasst von Cebrail Akyuz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Haydarpasa Numune Training and Research Hospital, University of Health Sciences, Istanbul 34668, Turkey. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Signet-ring cell colorectal cancer (SRCC) and colorectal cancer with a signet-ring cell component (SRC) are rare histological subtypes associated with poor prognosis. Although these entities are classified separately based on pathological criteria, it remains unclear whether they differ in clinical behavior and survival outcomes. This study aimed to compare the clinicopathological characteristics and survival of patients with SRCC and SRC.

Methods

Patients who underwent surgery for colorectal cancer (CRC) between January 2012 and December 2019 and were diagnosed with SRCC or SRC on histopathological examination were retrospectively included. Demographic, clinical, and survival data were analyzed and compared between the two groups.

Results

A total of 32 patients (22 males, 10 females) with SRCC or SRC were included, representing 2.6% (32/1253) of all CRC cases operated at our center. Seven patients (five with SRCC and two with SRC) had synchronous distant metastases, including liver-only metastases (9%), diffuse intra-abdominal seeding (9%), and ovarian metastasis (3%). The mean disease-free survival was 19.2 ± 3.3 months overall, and 17.18 ± 3.61 months for SRCC and 19.3 ± 9 months for SRC. The mean overall survival was 70.9 ± 10.18 months overall, and 65.95 ± 13.77 months for SRCC and 79.20 ± 15.03 months for SRC. No statistically significant difference in overall survival was observed between the groups (p = 0.534).

Conclusions

SRCC and SRC demonstrate broadly similar clinicopathological features, with younger age at diagnosis observed in SRCC patients. However, given the limited sample size, the absence of statistically significant differences in survival outcomes should be interpreted with caution and does not imply equivalence. Distant metastasis remains the most important prognostic factor in both groups.

Schlagwörter

Stichwörter der Autor:innen

coloncolorectal carcinomaprognosisrectumsignet-ring cell

Autor:innen und Institutionen

  • Department of General Surgery, Haydarpasa Numune Training and Research Hospital, University of Health Sciences, Istanbul 34668, Turkey.
  • Department of General Surgery, Gaziantep City Hospital, University of Health Sciences, Gaziantep 27500, Turkey.
  • Department of General Surgery, Martin Luther Hospital, 14193 Berlin, Germany.
  • Department of General Surgery, Bilecik Seyh Edebali University, Bilecik 11100, Turkey.
  • Department of General Surgery, Istanbul Medical Faculty, University of Istanbul, Istanbul 34093, Turkey.
  • Department of General Surgery, Bakirkoy Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul 34149, Turkey.

ORCID-Profile: Cebrail Akyuz, Oguzhan Sunamak, Aytac Selman, Mehmet O Gul, Kadir Corbaci, Feza Ekiz, Turgut Donmez, Evren Besler

Zitieren

APA

Akyuz, C., Sunamak, O., Selman, A., Gul, M. O., Kina Kilicaslan, U., Corbaci, K., Ekiz, F., Donmez, T., & Besler, E. (2026). Signet-Ring Cell Colorectal Cancer and Signet-Ring Cell Component Colorectal Cancer: Do They Differ in Clinical Behavior?. Journal of Clinical Medicine, 15(7), 2736. https://doi.org/10.3390/jcm15072736

Vancouver

Akyuz C, Sunamak O, Selman A, Gul MO, Kina Kilicaslan U, Corbaci K, et al. Signet-Ring Cell Colorectal Cancer and Signet-Ring Cell Component Colorectal Cancer: Do They Differ in Clinical Behavior?. Journal of Clinical Medicine. 2026;15(7):2736. doi:10.3390/jcm15072736

BibTeX
@article{Akyuz2026,
  author = {Akyuz, Cebrail and Sunamak, Oguzhan and Selman, Aytac and Gul, Mehmet O and Kina Kilicaslan, Umut and Corbaci, Kadir and Ekiz, Feza and Donmez, Turgut and Besler, Evren},
  title = {Signet-Ring Cell Colorectal Cancer and Signet-Ring Cell Component Colorectal Cancer: Do They Differ in Clinical Behavior?},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {2736},
  doi = {10.3390/jcm15072736}
}
Kostenlos starten →